18 results
8-K
EX-99.1
KROS
Keros Therapeutics Inc
4 Aug 20
Keros Therapeutics, Inc. Announces Completion of Dosing of Planned Cohorts in KER-047 Phase 1 Trial and Provides Program Update
8:32am
inpatient stays and 1.7 million outpatient encounters annually, Brigham Health’s 1,200 physicians provide expert care in virtually every medical
DEF 14A
1p5mm
19 Apr 21
Definitive proxy
4:15pm
424B5
3n179 ct2d01n519c
3 Jan 24
Prospectus supplement for primary offering
4:04pm
424B5
pbi3kfyezi5d1xopx8m4
4 Jan 24
Prospectus supplement for primary offering
4:02pm
DRS
gvu qc6uo3i
3 Nov 20
Draft registration statement
12:00am
DRS
obxvux
21 Jan 20
Draft registration statement
12:00am
S-1
6crayey3
16 Mar 20
IPO registration
4:57pm
424B4
cedshf6z
8 Apr 20
Prospectus supplement with pricing info
4:58pm
424B4
54qco
13 Nov 20
Prospectus supplement with pricing info
4:02pm
DRS/A
09cwtxeft v5
27 Feb 20
Draft registration statement (amended)
12:00am
10-K
sel5hbsg
25 Mar 21
Annual report
8:23am
- Prev
- 1
- Next